Cargando…
Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells
BACKGROUND: Anti-cancer drugs are widely used in cancer treatment frequently combined with surgical therapy and/or radiation therapy. Although surgery and radiation have been suggested to facilitate invasion and metastasis of tumor cells in some cases, there is so far little information about the ef...
Autores principales: | Eitaki, Masato, Yamamori, Tohru, Meike, Shunsuke, Yasui, Hironobu, Inanami, Osamu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3522013/ https://www.ncbi.nlm.nih.gov/pubmed/23057787 http://dx.doi.org/10.1186/1471-2407-12-469 |
Ejemplares similares
-
A nucleoside anticancer drug, 1-(3-C-ethynyl-β-D-ribo-pentofuranosyl)cytosine (TAS106), sensitizes cells to radiation by suppressing BRCA2 expression
por: Meike, Shunsuke, et al.
Publicado: (2011) -
PDZRhoGEF and myosin II localize RhoA activity to the back of polarizing neutrophil-like cells
por: Wong, Kit, et al.
Publicado: (2007) -
RhoA‐ROCK competes with YAP to regulate amoeboid breast cancer cell migration in response to lymphatic‐like flow
por: Mohammadalipour, Amina, et al.
Publicado: (2022) -
Tension on JAM-A activates RhoA via GEF-H1 and p115 RhoGEF
por: Scott, David W., et al.
Publicado: (2016) -
Autophagy suppresses cell migration by degrading GEF-H1, a RhoA GEF
por: Yoshida, Tatsushi, et al.
Publicado: (2016)